4//SEC Filing
Finnerty Thomas 4
Accession 0001171843-21-001710
CIK 0000898437other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 5:10 PM ET
Size
7.8 KB
Accession
0001171843-21-001710
Insider Transaction Report
Form 4
Finnerty Thomas
Chief Human Resources Officer
Transactions
- Award
Restricted Stock Unit
2021-03-09+7,645→ 7,645 totalExercise: $0.00→ Common Stock (7,645 underlying) - Award
Stock Option (Right to Buy)
2021-03-09+19,158→ 19,158 totalExercise: $37.40Exp: 2031-03-09→ Common Stock (19,158 underlying)
Footnotes (3)
- [F1]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
- [F2]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
- [F3]The premium priced stock options vest in three equal annual installments beginning on March 9, 2022.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001720871
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 5:10 PM ET
- Size
- 7.8 KB